You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 10, October 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Surgical Physiology, Other
 •Prognosis/ Outcomes
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Significance of Circulating B-Type Natriuretic Peptide in Sepsis—Reply

Emad Kandil, MD; Martin H. Bluth, MD, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Dr Fujita raises important issues. Natriuretic peptides emerged during recent years as potent prognostic markers in patients with heart failure and acute myocardial infarction. In addition, natriuretic peptides show strong predictive value in patients with pulmonary embolism, sepsis, renal failure, and shock. Our recently published study tests the prognostic information of BNP in a cohort of critically ill patients with septic shock. We have demonstrated that BNP concentrations are significantly increased in patients with septic shock and may play an important role in risk stratification in these patients independent of congestive heart failure. It could very well be that changes or the rate of elevation in BNP concentrations may be an important component of disease prognostication in sepsis. Similar concerns were raised when prostate-specific antigen was being investigated as a marker for prostate cancer. Numerous approaches were deemed of value . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

B-Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock
Emad Kandil, Joshua Burack, Ahmed Sawas, Haidy Bibawy, Alex Schwartzman, Michael E. Zenilman, and Martin H. Bluth
Arch Surg. 2008;143(3):242-246.
ABSTRACT | FULL TEXT  

RELATED LETTER

Significance of Circulating B-Type Natriuretic Peptide in Sepsis
Tetsuji Fujita
Arch Surg. 2008;143(10):1021-1022.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.